FindTrial
Sign In

The effects of Plasma-Lyte A solution on cardiac surgery under cardiopulmonary bypass: a retrospective study

The effects of Plasma-Lyte A solution on cardiac surgery under cardiopulmonary bypass: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032258
Enrollment
Unknown
Registered
2020-04-24
Start date
2020-05-30
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Valvular heart disease

Interventions

large volume balanced ultrafiltration group:large volume balanced ultrafiltration
Small volume balanced ultrafiltration group:Small volume balanced ultrafiltration

Sponsors

Xiangya Hospital, Centrsl South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Adult patients undergoing valve replacement valve or valve repairment under cardiopulmonary bypass were selected. The age should between 18-60 years old, with NYHA class II~III cardiac function preoperationally.

Exclusion criteria

Exclusion criteria: Patients with infective endocarditis; Patients with complex coronary heart disease, congenital heart disease and macrovascular disease; Patients with obvious preoperative pulmonary and renal dysfunction; Patients undergoing endoscopic heart surgery.

Design outcomes

Primary

MeasureTime frame
Ultrafiltration fluid inflammatory medium concentration;Coagulation function;cardiac function;Lung function;kidney function;—

Countries

China

Contacts

Public ContactZhang Chenliang

Xiangya Hospital, Central South University

zhangchengliang@csu.edu.cn+86 13874858442

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026